How Does Olaparib 150 mg Fit Into Ovarian Cancer Maintenance Treatment?
By Globans Pharma 22-08-2026 1
Sometimes, ovarian cancer tends to come back even after its first treatment via surgical operation and chemotherapy. In patients with a positive response towards chemotherapy using platinum, maintenance treatment might be helpful in prolonging the remission period. Olaparib is one of the drugs that can be administered in some patients for the maintenance of their ovarian cancer. The medication called Olaparib 150mg Tablet is an example of maintenance therapy which can be prescribed to certain patients with ovarian cancer.
What Is Olaparib 150mg?
The medicine is part of a class of drugs known as PARP inhibitors. The PARP proteins are important for the repair of specific kinds of DNA damage in cells. Some cancers that have DNA repair problems, such as those with mutated BRCA genes, may be more dependent on PARP for their DNA repair. Blocking the function of PARP by the medicine can affect DNA repair in these cancer cells and result in DNA damage leading to cell death.
Why Is The Tablet Used as Maintenance Therapy?
Maintenance therapy is administered when the first line of treatment has managed to control the disease. The rationale behind maintenance therapy is not the same as the rationale behind chemotherapy for an active tumor. Its eligibility for use depends on various considerations, including:
Ovarian Cancer Type and Stage
Response to Prior Platinum Containing Chemotherapy
Presence of BRCA Mutation
Other Tumor or Genetic Characteristics
Prior Treatments and Patient Health
How Does BRCA Status Matter?
The BRCA1 and BRCA2 genes have a key function in repairing DNA damage using the process of homologous recombination repair. Defective BRCA genes may interfere with the process of repair of the cancer cells. Olaparib is a medication that works by blocking the function of PARP enzymes, which repair certain DNA damages. If a patient has cancer cells with defects in BRCA repair, the medicine will inhibit the action of PARP enzymes and make repair difficult, resulting in cell death. A BRCA test is not used to determine whether each and every patient qualifies for the tablet. The oncologist takes into account many factors, including the patient's health condition.
How Is The Medicine Taken?
It is provided in tablet form in various doses. Medicine in 150mg dosage form is generally preferred for use in a specified dose regimen. Dosage and the course of treatment will have to be decided by an oncologist. Adjustment of dosage may be necessary according to individual conditions like renal function, adverse effects, interactions with drugs, etc. Patients must use the tablet in exactly the way it is recommended and must never alter dosage without consulting their doctor.
What Side Effects Can Occur During The Treatment?
Just like other cancer-fighting therapies, this medication may also have some side effects. The common ones include:
Nausea or vomiting
Weakness or fatigue
Headaches
Reduced appetite
Constipation or diarrhea
Anemia and other changes in blood cell count
There are some less common yet more severe complications as well. Medical checks help in the timely diagnosis of the severe side effects.
What Should Patients Know About The Medicine Price?
There are various factors that may determine the Olaparib 150mg Tablet Price such as the manufacturing company, brand name, pack quantity, pharmacy, locality, among others. The patient should consult the current price from a legitimate pharmacy or authorized drug provider like Globans Pharma that can provide information about product availability, pricing, and the appropriate purchasing process.
Conclusion
Maintenance treatment with Olaparib 150mg in ovarian cancer patients is a great choice who have shown sensitivity to platinum-based agents and possess the specific DNA repair profile. Being a PARP-inhibitor, this medication can delay tumor growth. However, the tablet should be used strictly according to the prescriptions of an oncologist.
FAQs
1. Should all ovarian cancer patients undergo genetic testing for BRCA before start taking treatment?
Genetic and tumour testing helps to identify whether the treatment will be beneficial for the patient. The doctor prescribing the treatment will decide what tests the patient should undergo.
2. Can the dosage of the tablet be altered?
Yes, it can be done due to certain clinical reasons such as the appearance of adverse reactions, kidney function and others. The dosage should not be altered by the patient herself.
Tags : .....
